Literature DB >> 17595787

Dermatofibrosarcoma protuberans: clinicopathological aspects of an unusual cutaneous tumor.

D P Korkolis1, I E Liapakis, P P Vassilopoulos.   

Abstract

Dermatofibrosarcoma protuberans is a rare cutaneous tumor with particular characteristics and a high frequency of recurrence after inadequate primary treatment. Its histopathological diagnosis might be difficult. Dermatofibrosarcoma protuberans can be safely distinguished from other similar neoplasms of mesenchymal origin based on the immunohistochemical expression of CD34 antigen and the genetic presence of specific chromosomal translocations. Although rarely metastatic, it is followed by a significantly high rate of locoregional failure due to an indolent subcuticular tissue spread. Aggressive surgical management is the therapeutic approach of choice. A wide resection with microscopically disease-free margins is always recommended. Mohs' micrographic surgery together with advanced reconstructive techniques provides satisfactory results even for tumors involving the face or distal extremities.

Entities:  

Mesh:

Year:  2007        PMID: 17595787

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Correlation Between Demographic and Tumor Characteristics in Non-melanoma Skin Cancers Submitted to Mohs Micrographic Surgery.

Authors:  Ellem T S Weimann; Caroline M BrandÃo; Luiz R Terzian; Francisco M Paschoal; Carlos D S Machado Filho; Paulo R Criado
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

2.  Dermatofibrosarcoma protuberans: A case report of a rare, bulky tumor that was managed with surgical therapy.

Authors:  Ahmet Yılmaz; Erol Cenesizoglu; Ertuğrul Eğilmez; Safa Onel; Mehdi Muştu; Ahmet Cennet
Journal:  Int J Shoulder Surg       Date:  2009-01

3.  A large gradually increasing cutaneous swelling on lower back.

Authors:  Gk Sawke; Nilima Sawke; Bs Gaur; S Thakur
Journal:  J Cutan Aesthet Surg       Date:  2010-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.